Alector, Inc.
Alector, Inc. (ALEC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ALEC · as of Jun 9, 2026
Key Statistics
Explore Alector, Inc. Data
alec stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 64.3%
The ALEC analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $2.00, representing +21.95% upside from the current price of $1.64.
Competitors & Peers
alec competitorsALEC
ABOS
APLT
CRBP
FATE
IRDStock Performance
Full HistoryAbout Alector, Inc.
Alector, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering new treatments for neurodegenerative disorders. A key program in its pipeline is AL001, a humanized recombinant mono…
what is alector, inc. · alec stock overview · alector, inc. company profile · who is alector, inc. ceo · alec NASDAQ · alector, inc. headquarters · alector, inc. business segments
About Stock Overview & Key Data
Alector, Inc. (ALEC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 7, 2019. As of the latest trading session, ALEC stock price is $1.64, with a market capitalization of $182.1M. The stock has returned +13.89% over the past 12 months and +5.13% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Alector, Inc. stock is Buy, with an average 12-month price target of $2.00. In fiscal year 2025, Alector, Inc. reported revenue of $21.0M and net income of -$142.9M. For detailed data — including Alector, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Alector, Inc. (ALEC) stock price is $1.64. The stock is traded on NASDAQ under the ticker symbol ALEC. The 52-week range is $1.09 – $3.40.